S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.97 (+0.68%)
AAPL   178.45 (-1.27%)
MSFT   412.54 (-0.27%)
META   499.44 (+1.90%)
GOOGL   137.66 (-0.58%)
AMZN   177.40 (+0.36%)
TSLA   199.57 (-1.14%)
NVDA   807.92 (+2.12%)
NIO   5.74 (-0.17%)
AMD   199.44 (+3.59%)
BABA   74.73 (+0.95%)
T   16.99 (+0.35%)
F   12.60 (+1.29%)
MU   95.76 (+5.68%)
CGC   3.20 (-2.74%)
GE   158.63 (+1.11%)
DIS   111.75 (+0.15%)
AMC   4.36 (+0.93%)
PFE   26.60 (+0.15%)
PYPL   61.53 (+1.97%)
XOM   105.92 (+1.34%)
S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.97 (+0.68%)
AAPL   178.45 (-1.27%)
MSFT   412.54 (-0.27%)
META   499.44 (+1.90%)
GOOGL   137.66 (-0.58%)
AMZN   177.40 (+0.36%)
TSLA   199.57 (-1.14%)
NVDA   807.92 (+2.12%)
NIO   5.74 (-0.17%)
AMD   199.44 (+3.59%)
BABA   74.73 (+0.95%)
T   16.99 (+0.35%)
F   12.60 (+1.29%)
MU   95.76 (+5.68%)
CGC   3.20 (-2.74%)
GE   158.63 (+1.11%)
DIS   111.75 (+0.15%)
AMC   4.36 (+0.93%)
PFE   26.60 (+0.15%)
PYPL   61.53 (+1.97%)
XOM   105.92 (+1.34%)
S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.97 (+0.68%)
AAPL   178.45 (-1.27%)
MSFT   412.54 (-0.27%)
META   499.44 (+1.90%)
GOOGL   137.66 (-0.58%)
AMZN   177.40 (+0.36%)
TSLA   199.57 (-1.14%)
NVDA   807.92 (+2.12%)
NIO   5.74 (-0.17%)
AMD   199.44 (+3.59%)
BABA   74.73 (+0.95%)
T   16.99 (+0.35%)
F   12.60 (+1.29%)
MU   95.76 (+5.68%)
CGC   3.20 (-2.74%)
GE   158.63 (+1.11%)
DIS   111.75 (+0.15%)
AMC   4.36 (+0.93%)
PFE   26.60 (+0.15%)
PYPL   61.53 (+1.97%)
XOM   105.92 (+1.34%)
S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.97 (+0.68%)
AAPL   178.45 (-1.27%)
MSFT   412.54 (-0.27%)
META   499.44 (+1.90%)
GOOGL   137.66 (-0.58%)
AMZN   177.40 (+0.36%)
TSLA   199.57 (-1.14%)
NVDA   807.92 (+2.12%)
NIO   5.74 (-0.17%)
AMD   199.44 (+3.59%)
BABA   74.73 (+0.95%)
T   16.99 (+0.35%)
F   12.60 (+1.29%)
MU   95.76 (+5.68%)
CGC   3.20 (-2.74%)
GE   158.63 (+1.11%)
DIS   111.75 (+0.15%)
AMC   4.36 (+0.93%)
PFE   26.60 (+0.15%)
PYPL   61.53 (+1.97%)
XOM   105.92 (+1.34%)

Flora Growth (FLGC) Competitors

$1.20
-0.02 (-1.23%)
(As of 10:27 AM ET)

FLGC vs. ADXS, ASLN, DRUG, VIRI, ERNA, ATHE, KTTA, AEZS, NEXI, and BNTC

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Ayala Pharmaceuticals (ADXS), ASLAN Pharmaceuticals (ASLN), Bright Minds Biosciences (DRUG), Virios Therapeutics (VIRI), Eterna Therapeutics (ERNA), Alterity Therapeutics (ATHE), Pasithea Therapeutics (KTTA), Aeterna Zentaris (AEZS), NexImmune (NEXI), and Benitec Biopharma (BNTC). These companies are all part of the "pharmaceutical preparations" industry.

Flora Growth vs.

Ayala Pharmaceuticals (NASDAQ:ADXS) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, community ranking, valuation, risk, dividends, media sentiment and earnings.

In the previous week, Flora Growth had 1 more articles in the media than Ayala Pharmaceuticals. MarketBeat recorded 2 mentions for Flora Growth and 1 mentions for Ayala Pharmaceuticals. Ayala Pharmaceuticals' average media sentiment score of 0.97 beat Flora Growth's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media.

Company Overall Sentiment
Ayala Pharmaceuticals Neutral
Flora Growth Positive

Flora Growth has a consensus target price of $20.00, indicating a potential upside of 1,559.75%. Given Ayala Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Flora Growth is more favorable than Ayala Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ayala Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Flora Growth
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Ayala Pharmaceuticals has higher earnings, but lower revenue than Flora Growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayala Pharmaceuticals$3.24M2.86N/AN/AN/A
Flora Growth$37.17M0.27-$52.42M-$10.02-0.12

Ayala Pharmaceuticals has a net margin of 0.00% compared to Ayala Pharmaceuticals' net margin of -84.86%. Ayala Pharmaceuticals' return on equity of -56.02% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Ayala PharmaceuticalsN/A -2,798.92% -195.41%
Flora Growth -84.86%-56.02%-33.95%

Flora Growth received 12 more outperform votes than Ayala Pharmaceuticals when rated by MarketBeat users. Likewise, 57.14% of users gave Flora Growth an outperform vote while only 0.00% of users gave Ayala Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Ayala PharmaceuticalsOutperform Votes
No Votes
Underperform Votes
29
100.00%
Flora GrowthOutperform Votes
12
57.14%
Underperform Votes
9
42.86%

Ayala Pharmaceuticals has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500.

Summary

Flora Growth beats Ayala Pharmaceuticals on 11 of the 13 factors compared between the two stocks.


Get Flora Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$9.89M$6.73B$4.95B$7.54B
Dividend YieldN/A2.82%2.87%3.87%
P/E Ratio-0.128.92188.3714.15
Price / Sales0.27223.123,003.0474.91
Price / CashN/A19.1096.0754.95
Price / Book0.084.854.534.68
Net Income-$52.42M$158.07M$114.14M$211.39M
7 Day Performance26.70%6.23%4.83%2.59%
1 Month Performance18.14%12.91%9.35%5.39%
1 Year Performance-85.44%6.85%12.70%8.68%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADXS
Ayala Pharmaceuticals
0 of 5 stars
$0.79
+8.2%
N/A-33.8%$8.47M$3.24M0.00N/AAnalyst Report
ASLN
ASLAN Pharmaceuticals
2.1707 of 5 stars
$0.52
flat
$15.67
+2,923.3%
-76.7%$8.47MN/A-0.1734Short Interest ↓
News Coverage
Gap Up
DRUG
Bright Minds Biosciences
0 of 5 stars
$1.90
-2.6%
N/A-37.5%$8.43MN/A-1.45N/APositive News
VIRI
Virios Therapeutics
0.5108 of 5 stars
$0.43
+13.2%
N/A+23.7%$8.28MN/A-1.304Short Interest ↑
News Coverage
Gap Up
ERNA
Eterna Therapeutics
0 of 5 stars
$1.53
-8.4%
N/A-59.5%$8.28M$51,000.00-0.379Gap Down
ATHE
Alterity Therapeutics
1.2921 of 5 stars
$2.01
-1.5%
$10.00
+397.5%
-41.7%$8.18M$3.37M0.0011Short Interest ↑
KTTA
Pasithea Therapeutics
3.0635 of 5 stars
$7.78
+7.8%
$40.00
+414.1%
-16.7%$8.11M$486,559.000.0015
AEZS
Aeterna Zentaris
1.9625 of 5 stars
$1.75
-3.8%
$15.00
+755.1%
-41.2%$8.86M$6.86M-0.3611Short Interest ↑
NEXI
NexImmune
0 of 5 stars
$8.56
+10.0%
N/A-37.7%$9.07MN/A-0.2022Short Interest ↓
Positive News
BNTC
Benitec Biopharma
2.8507 of 5 stars
$2.96
-0.7%
$10.00
+237.8%
-4.9%$7.67M$80,000.000.0017Short Interest ↓
Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:FLGC) was last updated on 3/1/2024 by MarketBeat.com Staff